Eplerenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system

Regulatory Peptides

Volumn 151, Issue 1-3, 2008, Pages 54-60

  De Mello, Walmor C ^a   Gerena, Yamil ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Aldosterone; Angiotensin II; Eplerenone; Failing heart; Intracrine; Inward calcium current

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM CHANNEL L TYPE; EPLERENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CARDIOMYOPATHY; CHANNEL GATING; CONTROLLED STUDY; DRUG MECHANISM; HEART FAILURE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN II; ANIMALS; CALCIUM SIGNALING; CARDIOMYOPATHIES; CRICETINAE; HEART FAILURE; MODELS, CARDIOVASCULAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, MINERALOCORTICOID; RENIN-ANGIOTENSIN SYSTEM; SPIRONOLACTONE;

ANIMALIA; CRICETINAE;

EID: 56549084712     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.06.003     Document Type: Article

References (30)

1. Pierce P., and Funder J.W. High affinity aldosterone binding sites (type 1 receptors) in rat heart. Clin Exp Pharmacol Physiol 14 (1987) 859-866
2. Lombes M., Oblin M.E., Gase J.M., Baulieu E.E., Framan N., and Bouvalet J.P. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 71 (1992) 503-510
3. Jaffe I.Z., and Mendelsohn M.E. Angiotensin II and aldosterone regulate gene transcription via functional mineralocorticoid receptors in human coronary artery smooth muscle cells. Circ Res 96 (2005) 643-650
4. Robert V., Heymes C., Silvestre J.S., Sabri A., Swynghedauw B., and Delcayre C. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt induced fibrosis. Hypertension 33 (1999) 981-986
5. Fraccarollo D., Galupo P., Schmidt I., Ertl G., and Baursachs J. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction. Cardiovasc Res 67 (2005) 97-105
6. Silvestre J.R., Robert V., Heymes C., Aupetit-Faisant B., Monas C., Moalic J.M., Swynghedauw B., and Delcayre C. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 273 (1998) 4883-4891
7. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79 (1999) 215-262
8. Delcayre C., Heymes C., Milliez P., and Swynghedauw B. Throphic effects of aldosterone. In: De Mello W.C. (Ed). In renin angiotensin system and the heart (2004), John Wiley and Sons, West Sussex pp 161-175
9. Mizuno Y., Yoshimura M., Yasue H., et al. Aldosterone production is activated in failing ventricles of humans. Circulation 103 (2001) 72-77
10. De Mello W.C. Renin angiotensin system and cell communication in the failing heart. Hypertension 27 (1996) 1267-1272
11. De Mello W.C., and Monterrubio J. The influence of intracellular and extracellular angiotensin II on the L-type calcium current in the failing heart. Hypertension 44 (2004) 360
12. Powell T., and Twist T. A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 72 (1976) 327-333
13. Tanigushi Y., Kokubun S., Noma A., and Irisawa H. Spontaneously active cells isolated from the sinoatrial and atrioventricular node of the rabbit heart. Jpn J Physiol 31 (1981) 547-558
14. Prussin C., and Metcalfe D.D. Detection of intracellular cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188 (1995) 117-128
15. Irisawa H., and Kokubun S. Modulation of intracellular ATP and cyclic AMP of the slow inward current in isolated single ventricular cells of the guinea pig. J Physiol 338 (1983) 321-337
16. De Mello W.C. Intracellular angiotensin II regulates the inward calcium current in cardiomyocytes. Hypertension 32 (1998) 976-982
17. De Mello W.C. Heart failure. How important is cellular sequestration?. The role of the renin angiotensin aldosterone system. J Mol Cell Cardiol 37 (2004) 431-438
18. Re R.N., LaBiche R.A., and Bryan S.E. Nuclear-hormone mediated changes in chromatin solubility. Biochem Biophys. Res Commun 110 (1983) 61-68
19. Fu M.L., Schulze W., Wallukat G., et al. Immunochemical localization of angiotensin II receptor (AT1) in the heart with anti-peptide antibody showing a positive chronotropic effect. Receptor Channels 6 (1998) 99-111
20. De Mello W.C. Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II. Reg Pept 115 (2003) 31-36
21. De Mello W.C., and Crespo M.J. Correlation between changes in morphology, electrical properties and angiotensin converting enzyme activity in the failing heart. Eur J Pharmacol 378 (1999) 187-194
22. De Mello W.C. Beneficial effects of eplerenone on cardiac remodeling and electrical properties of the failing heart. J Renin Angiotensin Aldosterone System 7 (2006) 40-46
23. Chai W., and Danser A.H.J. Why are mineralocorticoid receptor antagonists cardioprotective?. Naunyn Schmiedebergs Arch Pharmacol 374 (2006) 153-162
24. Takeda Y., Zhu A., Yoneda T., Usukura M., et al. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and ACE2 expression in Dahl-salt-sensitive rats. Am J Hypertns 20 (2007) 1119-1124
25. Gomez-Sanchez E., Ahmad N., Romero D.G., and Gomez-Sanchez C.E. Origin of aldosterone in the rat heart. Endocrinology 145 (2004) 4796-4802
26. Fiebeler A., Nussberger J., Schgdarsuren E., Rong S., Hilfenhaus G., Al-Saadi N., et al. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation 111 (2005) 3087-3094
27. Chai W., Garrelds I.M., de Vries R., and Danser A.H. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derivative aldosterone ?. Hypertension 47 (2006) 665-670
28. Kobayashi N., Yoshida K., Nakano S., Ohno T., Honda T., et al. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension 47 (2006) 671-679
29. Nagata K., Obata K., Xu J., Ichihara S., Noda A., et al. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 47 (2006) 656-664
30. Delcayre C., and Swynghedauw B. Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Mol Cell Cardiol 34 (2002) 1577-1584